Structure Therapeutics Inc. (GPCR) Balance Sheet

NASDAQ: GPCRAssets, liabilities, debt and equity over 6 years.

GPCR balance sheet, 2025

December 31, 2025 · U.S. dollars

$1.58B assets = $67.5M liabilities + $1.52B equity

What it owns$1.58BCash & ST investments: $1.45B (91.3%)Cash & ST investments$1.45B · 91%Other current: $124.1M (7.8%)Other current $124.1MPP&E: $12.9M (0.8%)Other non-current: $717,000 (0.0%)=How it is financed$1.58BCurrent liabilities: $63.3M (4.0%)Other LT liabilities: $4.3M (0.3%)Shareholders’ equity: $1.52B (95.7%)Shareholders’ equity$1.52B · 96%

Both columns are drawn to the same scale: what GPCR owns equals what it owes plus shareholders’ equity. Hover a block for its value.

GPCR financial health

Debt / equity0.00
Low leverage · $0.00 of debt for each $1 of equity
Equity / assets95.7%
Equity-funded · of assets funded by shareholders
Cash / debt22,293.8%
Cash covers debt · cash & short-term investments vs total debt
Goodwill & intangibles0.0%
Mostly tangible · of total assets

Descriptive bands, not a rating. Fiscal 2025.

GPCR balance sheet trends, 2020–2025

Structure Therapeutics Inc. balance sheet trends
MetricTrendThenLatestChange
Total assets$38.7M2020$1.58B2025+110.1%/yr
Total liabilities$61.2M2020$67.5M2025+2.0%/yr
Shareholders’ equity−$22.5M2020$1.52B2025—
Cash & short-term investments$37.4M2020$1.45B2025+107.7%/yr
Total debt$280,0002020$6.5M2025+87.5%/yr
Net cash (debt)$37.2M2020$1.44B2025+$1.4B
Working capital$35.4M2020$1.51B2025+$1.5B
Book value per share−$0.612020$25.622025—
Debt / equity0.0120230.002025−0.01
Shares outstanding36.6M202059.2M2025+10.1%/yr

Change is the average annual growth (CAGR) or the difference between the first and latest year.

GPCR assets

Cash & ST investmentsReceivablesInventoryOther currentPP&EGoodwill & intangiblesLT investmentsOther non-current

GPCR liabilities and equity

Current liabilitiesLong-term debtOther long-term liabilitiesEquity

GPCR debt vs cash

Total debtCash & ST investmentsNet cash (debt)

Debt includes short- and long-term borrowings and, where reported, lease obligations.

GPCR balance sheet

Structure Therapeutics Inc. annual balance sheet
202520242023202220212020
Assets
Cash & short-term investments$1.45B$883.5M$467.3M$90.8M$107.3M$37.4M
Cash & equivalents$799.6M$169.5M$129.8M$26.1M$105.3M$16.4M
Short-term investments$646.6M$714.0M$337.5M$64.8M$2.0M$21.1M
Receivables$0$0$0$0$0$0
Inventory$0$0$0$0$0$0
Other current assets$124.1M$7.7M$6.3M$2.2M$1.9M$974,000
Total current assets$1.57B$891.2M$473.6M$93.1M$109.2M$38.4M
Property, plant & equipment (net)$12.9M$7.0M$8.4M$1.3M$1.8M$277,000
Goodwill & intangible assets$0$0$0$0$0$0
Long-term investments$0$0$0$0$0$0
Other non-current assets$717,000$5.1M$45,000$3.5M$111,000$8,000
Total assets$1.58B$903.3M$482.0M$97.8M$111.2M$38.7M
Liabilities
Accounts payable$13.9M$8.0M$4.7M$6.0M$3.5M$1.5M
Short-term debt$2.9M$1.7M$1.4M$260,000$349,000$147,000
Deferred revenue——$356,001———
Total current liabilities$63.3M$36.0M$24.7M$13.0M$8.7M$3.0M
Long-term debt$0$0$0$0$0$0
Lease obligations$6.5M$3.9M$5.5M$260,000$621$280
Other long-term liabilities$4.3M$2.5M$4.3M$200.0M$167.2M$58.1M
Total liabilities$67.5M$38.5M$29.1M$213.0M$175.9M$61.2M
Shareholders' equity
Common stock & paid-in capital$21,000$17,000$14,000$1,000$1,000$1,000
Retained earnings (deficit)−$470.3M−$329.1M−$206.6M−$117.0M−$64.7M−$22.9M
Accumulated other comprehensive income$1.1M$914,000$521,000−$110,000−$167.0M−$1,000
Total shareholders' equity$1.52B$864.8M$453.0M−$115.1M−$64.7M−$22.5M
Key figures
Total debt$6.5M$3.9M$5.5M$260,000$621,000$280,000
Net cash (debt)$1.44B$879.7M$461.9M$90.6M$106.7M$37.2M
Working capital$1.51B$855.2M$448.9M$80.1M$100.6M$35.4M
Tangible book value$1.52B$864.8M$453.0M−$115.1M−$64.7M−$22.5M
Book value per share$25.62$16.43$12.33−$3.15−$1.77−$0.61
Shares outstanding59.2M52.6M36.7M36.6M36.6M36.6M
Current ratio24.8124.7419.147.1612.6212.64
Quick ratio22.8524.5318.896.9812.3912.32
Debt / equity0.000.000.01———
Equity / assets95.7%95.7%94.0%−117.7%−58.2%−58.1%

Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported (latest annual report filed February 26, 2026); data from EODHD.

GPCR financial position

At the end of fiscal 2025 (December 31, 2025), Structure Therapeutics had total assets of $1.6 billion (up 75.3% from a year earlier), total liabilities of $67.5 million and shareholders' equity of $1.5 billion. It held $1.4 billion in cash and short-term investments against $6.5 million of debt, a net cash position of $1.4 billion. Its current ratio was 24.81. In the latest quarter (ended June 30, 2026) total assets were $1.4 billion and equity $1.4 billion.

Related: GPCR income statement, GPCR cash flow statement, GPCR key metrics. See the GPCR stock overview for the latest quote and news.

GPCR balance sheet FAQ

What are Structure Therapeutics's total assets?

Structure Therapeutics reported total assets of $1.6 billion at the end of fiscal 2025 (December 31, 2025), compared with $903.3 million a year earlier.

How much debt does Structure Therapeutics have?

Structure Therapeutics had $6.5 million of total debt at the end of fiscal 2025, including short-term borrowings and lease obligations. Its debt-to-equity ratio was 0.00.

How much cash does Structure Therapeutics have?

Structure Therapeutics held $1.4 billion in cash and short-term investments at the end of fiscal 2025; with $6.5 million of debt that is net cash of $1.4 billion.

What is Structure Therapeutics's book value?

Structure Therapeutics's shareholders' equity (book value) was $1.5 billion at the end of fiscal 2025, or $25.62 per share.

What is Structure Therapeutics's current ratio?

Structure Therapeutics had current assets of $1.6 billion and current liabilities of $63.3 million, a current ratio of 24.81 (it can cover its short-term obligations).

Biotechnology: balance sheet